Biotech ETF XBI Falls 3.27% While Five Large Sector Stocks Slip Less
State Street's biotech ETF fell 3.27% on Thursday, a deeper drop than any of five large sector stocks (down 0.22% to 1.15%). An Amgen target raise and a Gilead campaign do not explain it.


